Blog

The rise and fall of IBM Watson Health represents one of the most instructive case studies in the history of enterprise computing, digital health, and clinical informatics. Marketed as a revolutionary breakthrough that would eliminate diagnostic errors and personalise oncology care globally, the enterprise culminated in a multi-billion-dollar strategic retreat, the cancellation of flagship academic partnerships, and the eventual liquidation of its assets.&nbsp; &nbsp;&nbsp; The collapse was not caused by a single algorithmic flaw, but by a structural failure spanning misaligned computational architecture, flawed training methodology, hyper-aggressive corporate marketing, and a fundamental misunderstanding of clinical workflows and medical epistemologies.Conclusion &nbsp;&nbsp; The collapse of IBM Watson Health stands as a landmark lesson in technological prematurity, governance failure and the perils of marketing-driven product expansion.&nbsp; IBM’s effort to automate oncological care failed because it attempted to reduce complex human biological reasoning to statistical pattern matching, trained its algorithms on biased synthetic data, and ignored the messy operational realities of clinical workflows. Compounded by expensive, unintegrated data acquisitions and a business model that mistook bespoke consulting for a scalable SaaS platform, Watson Health became unsustainable.&nbsp; Ultimately, the liquidation of Watson Health catalysed a necessary maturation across the digital health ecosystem, establishing that meaningful transformation in healthcare AI requires deep clinical alignment, objective real-world evidence, absolute algorithmic transparency, and continuous validation over corporate narrative.Click here to read the report <a href="https://www.healthcare.digital/single-post/the-collapse-of-ibm-watson-health-a-post-mortem-on-technological-prematurity-governance-failure-a">https://www.healthcare.digital/single-post/the-collapse-of-ibm-watson-health-a-post-mortem-on-technological-prematurity-governance-failure-a</a>

The rise and fall of IBM Watson Health represents one of the most instructive case studies in the history of enterprise computing, digital health and clinical informatics.

Nelson Advisors has been referenced in Springer Nature article 'Dynamic Multi-agent Healthcare Systems: Optimizing Resource Allocation for Aging Societies'Source: <a href="https://link.springer.com/chapter/10.1007/978-3-032-06531-5_82">https://link.springer.com/chapter/10.1007/978-3-032-06531-5_82</a>Healthcare systems globally face increasing strain from aging populations, resource constraints and fragmented policy structures. In Europe, demographic aging is accelerating healthcare demand, exposing gaps in capacity and coordination. This study proposes a Multi-Agent System (MAS) framework to optimise resource allocation, policy response and inter-institutional coordination. By simulating hospitals, clinics, policymakers and patients as autonomous agents, the system supports real-time decision-making under conditions such as staff shortages, aging infrastructure and evolving care needs. Leveraging synthetic data generation and federated learning, the MAS is trained on diverse demographic scenarios - including rural-urban disparities and migratory pattern whilst preserving privacy. A scenario test demonstrates the model’s ability to reduce patient wait times by 35%, cut operational costs by 20% and improve bed turnover by 25% through adaptive agent coordination. Ethical safeguards ensure transparency and fairness, aligned with EU regulatory standards. The MAS offers a scalable, simulation-based tool for healthcare stakeholders to anticipate resource gaps, test policy interventions and strengthen systemic resilience in aging societies.“TaaS - treatment as a service: emerging healthtech sub sector is one to watch in 2024 and 2025. &nbsp; &nbsp; &nbsp; Nelson Advisors &gt; Healthcare Technology Thought Leadership, 22 July 2024. <a href="https://www.healthcare.digital/single-post/taas-treatment-as-a-service-emerging-healthtech-sub-sector-is-one-to-watch-in-2024-and-2025">https://www.healthcare.digital/single-post/taas-treatment-as-a-service-emerging-healthtech-sub-sector-is-one-to-watch-in-2024-and-2025﻿</a>. Accessed 21 Apr 2025

Nelson Advisors referenced in Springer Nature article 'Dynamic Multi-agent Healthcare Systems: Optimizing Resource Allocation for Aging Societies'

Nelson Advisors has been referenced in Investopedia article 'Google Glass Failure: Examining Costs, Privacy and Tech Hurdles.'Source: <a href="https://www.investopedia.com/articles/investing/052115/how-why-google-glass-failed.asp">https://www.investopedia.com/articles/investing/052115/how-why-google-glass-failed.asp</a>Google Glass was one of Google X's ambitious "moonshot" projects, designed to revolutionize everyday technology through wearable smart glasses. Launched in 2014 as a futuristic innovation, it was quickly pulled from the consumer market in 2015 due to its high cost, privacy concerns, and public confusion about its purpose.Although Google later attempted to revive Glass for enterprise and professional use, the product struggled to gain traction and was ultimately discontinued in 2023.What Were Some of the Technological Limitations of Google Glass? Surveys found that hardware and network limitations existed with failures in transmitting images, lost connections, and sudden restarts.10Healthcare Digital. "Why did Google Glass fail in Healthcare and overall with consumers?"<a href="https://www.healthcare.digital/single-post/why-did-google-glass-fail-in-healthcare-and-overall-with-consumers">https://www.healthcare.digital/single-post/why-did-google-glass-fail-in-healthcare-and-overall-with-consumers</a>

Nelson Advisors referenced in Investopedia article 'Google Glass Failure: Examining Costs, Privacy and Tech Hurdles'

Nelson Advisors has been referenced in 'Health Analytics in Business Research' publication by Copenhagen Business School students Liu, Quanchen; Yu, Mengli; Xiong, Bingqing; Cai, Zhao; Zhang, Pengzhu; Tan, Chee-Wee.Source: <a href="https://research-api.cbs.dk/ws/portalfiles/portal/102251411/quanchen_liu_et_al_health_analytics_in_business_research_acceptedversion.pdf" data-mce-href="https://research-api.cbs.dk/ws/portalfiles/portal/102251411/quanchen_liu_et_al_health_analytics_in_business_research_acceptedversion.pdf">https://researchapi.cbs.dk/ws/portalfiles/portal/102251411/quanchen_liu_et_al_health_analytics_in_business_research_acceptedversion.pdf</a>HEALTH ANALYTICS APPLICATIONS IN DIFFERENT BUSINESS TOPICSThe above word cloud illustrates that topics in health analytics primarily encompass patients and healthcare delivery organizations. Scholars in other fields have proposed classification schemes from different research perspectives. As Dr. Niti Pall, a visionary global senior clinical leader, pointed out in her lessons 7, “The focus is on patient-facing technologies. Others are professional-facing and organization-facing technologies depending on their primary user and value in enhancing individual patient care or improving care systems. The electronic health record spans the entire system and serves as the foundation for many other applications.” Figure 4 illustrates her holistic view of the future development of digital health. Herein, different wellbeing status of patients are grouped in a central location. A variety of IT-based devices are used by patients to communicate with healthcare professionals and exchange key information.Various digital technologies are used by medical professionals to monitor, measure, and diagnose patients' potential health problems to improve their decision-making process. Niti believes that electronic health records (EHRs) form a vital link between patients, professionals and organizations in the growing world of digital medical care. wellbeing status of patients are grouped in a central location. A variety of IT-based devices are7 URL: https://www.healthcare.digital/single-post/2019/02/26/seven-key-lessons-learnt-from-digital-transformation-by-healthcare-providers-around-the-w, accessed March 30th, 2023

Nelson Advisors referenced in 'Health Analytics in Business Research' publication by Copenhagen Business School students

Nelson Advisors has been referenced in Doctor Care Anywhere's article 'The thinking behind our Medicspot acquisition - and why it’s different'.Source: <a href="https://investors.doctorcareanywhere.com/activity-updates/rvWLMP-why-we-moved-into-weight-management">https://investors.doctorcareanywhere.com/activity-updates/rvWLMP-why-we-moved-into-weight-management</a>Something unusual has happened in UK healthcare over the last three years. GLP-1 weight-loss treatment, barely used by consumers in 2022, is now one of the fastest-growing areas of private healthcare in the country. Around 3 million UK adults use these medications, the vast majority paying privately, since the NHS reaches only a narrow eligibility group (PwC, 2026). PwC expects that number to more than double as pill versions arrive.You’ll recognise this pattern wherever you’re reading from. In Australia, more than 400,000 people already pay privately for these drugs (there’s still no PBS subsidy for the obesity indication), and Eucalyptus, the group behind Pilot and Juniper, just sold to Hims &amp; Hers forUS$1.15 billion, near 4.6 times revenue, with its UK business now bigger than its Australian one. The market has put a very large number on this category. That’s worth keeping in mind against what we paid.The dealIn May we acquired Medicspot, a direct-to-consumer GLP-1 weight-loss service founded in 2016:• &nbsp; &nbsp; &nbsp; £850,000 in cash, paid on completion - no earn-out, no deferred consideration.• &nbsp; &nbsp; &nbsp; £5.3 million revenue in the twelve months to March 2026, broadly breakeven on EBITDA.• &nbsp; &nbsp; &nbsp; Roughly 0.16 times sales - a fraction of the ~4.6 times revenue Eucalyptus sold for.• &nbsp; &nbsp; &nbsp; Funded entirely from existing cash.Medicspot and Eucalyptus aren’t directly comparable, but the gap illustrates the kind of asymmetry we look for: a validated, fast-growing category, bought before Medicspot has contributed a full year of revenue or any cross-sell benefit.Healthcare.digital (2026) Global Health Convergence: Analysis of the $1.15 Billion Acquisition of Eucalyptus by Hims &amp; Hers Health. Available at: <a href="https://www.healthcare.digital/single-post/global-health-convergence-analysis-of-the-1-15-billion-acquisition-of-eucalyptus-by-hims-hers-he">https://www.healthcare.digital/single-post/global-health-convergence-analysis-of-the-1-15-billion-acquisition-of-eucalyptus-by-hims-hers-he</a>.

Nelson Advisors referenced in Doctor Care Anywhere's article 'The thinking behind our Medicspot acquisition - and why it’s different'

Nelson Advisors has been referenced in YouTrust's article 'How to Update a Shareholder Agreement After a Funding Round'.Source: <a href="https://youtrust.com/blog/how-to-update-shareholder-agreement-after-funding-round">https://youtrust.com/blog/how-to-update-shareholder-agreement-after-funding-round</a>Anti-Dilution Protections and Founder VestingInvestors in later rounds often negotiate anti-dilution clauses protecting the value of their investment if future shares are issued at a lower price. The most common forms are broad-based weighted average and full ratchet, each with significantly different economic consequences for founders. Separately, if founders are still vesting, the agreement should confirm whether the new round affects the vesting schedule, and good leaver and bad leaver provisions should be reviewed to ensure they reflect the current team composition.<a href="https://nelsonadvisors.co.uk/blog/understanding-anti-dilution-protection-clauses-for-venture-capitalists--a-cheat-sheet-for-healthtech-founders" data-mce-selected="inline-boundary">﻿https://nelsonadvisors.co.uk/blog/understanding-anti-dilution-protection-clauses-for-venture-capitalists--a-cheat-sheet-for-healthtech-founders﻿</a> &nbsp;

Nelson Advisors

Blog

The rise and fall of IBM Watson Health represents one of ...

Nelson Advisors referenced in Springer Nature article 'Dy...

Nelson Advisors referenced in Investopedia article 'Googl...

Nelson Advisors referenced in 'Health Analytics in Busine...

Nelson Advisors referenced in Doctor Care Anywhere's arti...

Nelson Advisors referenced in YouTrust's article 'How to ...